[Metabolic disorders in emerging and neglected infectious diseases]

Arq Bras Endocrinol Metabol. 2010 Dec;54(9):785-92. doi: 10.1590/s0004-27302010000900003.
[Article in Portuguese]

Abstract

The gradual and progressive replacement of infectious and parasitic by chronic diseases as causes of morbidity and mortality, characterizing the process of epidemiological transition hasn't been observed in various populations, especially in underdeveloped or developing countries characterizing a superposition of these profiles (incomplete transition). Besides the increased prevalence of metabolic disorders, various infectious diseases remain endemic in several regions, such as leprosy, tuberculosis, leishmaniasis, viral hepatitis, among others, as well as emerging diseases in recent decades, as HIV infection/Aids. In this context, more attention has been given to the occurrence of metabolic disturbances in the recent years, mainly from the observation of a high incidence of metabolic disorders associated with HIV infection/Aids, and its therapy with antiretroviral drugs. This review addresses clinical and epidemiological aspects of metabolic disturbances reported in some infectious and parasitic diseases with worldwide and local (Brazil) relevance, as well as possible mechanisms and factors involved in these associations.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome / epidemiology
  • Communicable Diseases, Emerging / epidemiology*
  • Developing Countries / statistics & numerical data*
  • Health Transition*
  • Humans
  • Neglected Diseases / epidemiology*